Stories
Stories
Accelerating Change on Medicine’s Final Frontier
Frustrated by the slow pace and poor success rate of entrepreneurial startups bringing innovation from bench to bedside in his field, Jordan Amadio (MD/MBA 2010) and two partners founded NeuroLaunch, the world’s first neuroscience-focused accelerator, to help fast-track new treatments and technologies.
“Innovation should be part of the mission of every physician,” says Amadio, currently chief resident in the neurological surgery residency program at Emory University, in Atlanta. “We have been at the medical game for several thousand years, and we still have so much to learn. Every physician has the responsibility to push the field forward.”
To date, NeuroLaunch has worked with 11 startups and is currently assembling a new group of applicants for its 90-day curated program, which focuses on product development, operations, clinical and regulatory affairs, and business development. Offices have opened in Boston and San Francisco, and now the company is raising additional capital to further expand its operations. Amadio wants to franchise the NeuroLaunch model worldwide, and he’s already in talks with groups in London, Singapore, and Israel.
“We’re helping the whole spectrum of neuroscience entrepreneurs capture the value around their ideas,” Amadio says. “I believe very strongly that we’re starting a movement. Neuroscience is medicine’s final frontier, and the 21st century will be the century of neuroscience.”
(Published September 2016)
Support the next generation of leaders Make a gift nowPost a Comment
Related Stories
-
- 01 Mar 2024
- HBS Alumni Bulletin
INK: Taking Care
Re: Kathy Giusti (MBA 1985) -
- 01 Dec 2023
- HBS Alumni Bulletin
Joint Venture
Re: Dushyanth Surakanti (MBA 2007); By: Shoshi Parks -
- 27 Apr 2023
- HBS Alumni News
Life Preserver
Re: Sebastian Eriksson Giwa (MBA 2009); By: April White -
- 17 Aug 2020
- Making A Difference
Democratizing Medicine
Re: Carlos Reines (MBA 2014)
Stories Featuring Jor Amadio
-
- 05 Aug 2016
- HBS Alumni News
Accelerating Change on Medicine’s Final Frontier
Re: Jor Amadio (MBA 2010); Mike Kelly (MBA 1990); David Gellis (MBA 2010); Vinod Nambudiri (MBA 2010); Greg Stock (MBA 1987); Jim Shinn (MBA 1981); By: Robert S. Benchley